Latest filings (excl ownership)
15-12B
Securities registration termination
7 Jan 20
EFFECT
Notice of effectiveness
18 Dec 19
EFFECT
Notice of effectiveness
18 Dec 19
EFFECT
Notice of effectiveness
18 Dec 19
EFFECT
Notice of effectiveness
18 Dec 19
EFFECT
Notice of effectiveness
18 Dec 19
EFFECT
Notice of effectiveness
18 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 19
POS AM
Prospectus update (post-effective amendment)
13 Dec 19
POS AM
Prospectus update (post-effective amendment)
13 Dec 19
POS AM
Prospectus update (post-effective amendment)
13 Dec 19
POS AM
Prospectus update (post-effective amendment)
13 Dec 19
POS AM
Prospectus update (post-effective amendment)
13 Dec 19
POS AM
Prospectus update (post-effective amendment)
13 Dec 19
S-8 POS
Registration of securities for employees (post-effective amendment)
13 Dec 19
25-NSE
Exchange delisting
13 Dec 19
8-K
Completion of Acquisition or Disposition of Assets
13 Dec 19
8-K
Submission of Matters to a Vote of Security Holders
10 Dec 19
8-K
Other Events
22 Nov 19
DEFA14A
Additional proxy soliciting materials
22 Nov 19
10-Q
2019 Q3
Quarterly report
14 Nov 19
DEFA14A
Additional proxy soliciting materials
12 Nov 19
DEFM14A
Proxy related to merger
28 Oct 19
PREM14A
Preliminary proxy related to merger
11 Oct 19
8-K/A
Submission of Matters to a Vote of Security Holders
26 Sep 19
8-K
Company Securityholder Voting and Support Agreement
13 Sep 19
DEFA14A
Additional proxy soliciting materials
13 Sep 19
8-K
Castle Creek Pharmaceutical Holdings to Acquire Fibrocell
12 Sep 19
DEFA14A
Additional proxy soliciting materials
12 Sep 19
S-8
Registration of securities for employees
29 Aug 19
8-K
Departure of Directors or Certain Officers
22 Aug 19
8-K
Results of Operations and Financial Condition
15 Aug 19
10-Q
2019 Q2
Quarterly report
14 Aug 19
8-K
Other Events
2 Jul 19
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 19
8-K
Other Events
29 May 19
10-Q
2019 Q1
Quarterly report
15 May 19
Latest ownership filings
4
RANDAL J KIRK
17 Dec 19
4
Marcus E. Smith
13 Dec 19
4
Julian P. Kirk
13 Dec 19
4
Christine St.Clare
13 Dec 19
4
Douglas J Swirsky
13 Dec 19
4
Kelvin Moore
13 Dec 19
4
John Michael Maslowski
13 Dec 19
4
Marc Mazur
13 Dec 19
4
Sean D. Buckley
13 Dec 19
SC 13G
Fibrocell Science, Inc.
25 Sep 19
SC 13D/A
Beneficial ownership report (amended)
17 Sep 19
4
Sean D. Buckley
19 Aug 19
4
Marc Mazur
14 Jun 19
4
Christine St.Clare
14 Jun 19
4
Kelvin Moore
14 Jun 19
4
Douglas J Swirsky
14 Jun 19
4
Julian P. Kirk
13 Jun 19
4
Marcus E. Smith
13 Jun 19
4
Sean D. Buckley
16 Apr 19
4
John Michael Maslowski
16 Apr 19
SC 13G/A
Fibrocell Science, Inc.
14 Feb 19
SC 13G/A
Fibrocell Science, Inc.
14 Feb 19
SC 13G/A
Fibrocell Science, Inc.
8 Feb 19
SC 13G/A
Fibrocell Science, Inc.
4 Jan 19
4
John Michael Maslowski
23 Aug 18
SC 13G
Fibrocell Science, Inc.
11 Jul 18
3
Sean D. Buckley
27 Jun 18
4
Kelvin Moore
21 Jun 18
4
Marc Mazur
21 Jun 18
4
Christine St.Clare
21 Jun 18
4
Douglas J Swirsky
21 Jun 18
4
Marcus E. Smith
21 Jun 18
4
Julian P. Kirk
21 Jun 18
SC 13G
Fibrocell Science, Inc.
7 Jun 18
SC 13G
Fibrocell Science, Inc.
1 Jun 18
SC 13G
Fibrocell Science, Inc.
31 May 18
SC 13G/A
Fibrocell Science, Inc.
13 Feb 18
4
John Michael Maslowski
29 Jan 18
4
RANDAL J KIRK
13 Dec 17
SC 13D/A
Fibrocell Science, Inc.
13 Dec 17